Clinicians managing conditions with a high disability burden such as musculoskeletal and respiratory diseases are unlikely to receive research funding from the government’s flagship $5 billion Medical Research Future Fund (MRFF), a new analysis shows. The MRFF is biased towards fatal diseases such as cancer and cardiovascular disease which receive disproportionate amount of research funding ...
MRFF bias against musculoskeletal research funding
By Michael Woodhead
16 Feb 2021